A Distinct Macrophage Population Mediates Metastatic Breast Cancer Cell Extravasation, Establishment and Growth
Open accessThe DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The stromal microenvironment and particularly the macrophage component of primary tumors influence their malignant potential. However, at the metastatic site the role of these cells and their mechanism of actions for establishment and growth of metastases remain largely unknown. METHODOLOGY/PRINCIPAL FINDINGS: Using animal models of breast cancer metastasis, we show that a population of host macrophages displaying a distinct phenotype is recruited to extravasating pulmonary metastatic cells regardless of species of origin. Ablation of this macrophage population through three independent means (genetic and chemical) showed that these macrophages are required for efficient metastatic seeding and growth. Importantly, even after metastatic growth is established, ablation of this macrophage population inhibited subsequent growth. Furthermore, imaging of intact lungs revealed that macrophages are required for efficient tumor cell extravasation. CONCLUSION/SIGNIFICANCE: These data indicate a direct enhancement of metastatic growth by macrophages through their effects on tumor cell extravasation, survival and subsequent growth and identifies these cells as a new therapeutic target for treatment of metastatic disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Clinical studies and experimental animal models suggest that TAM commonly plays a pro-tumoral role in various ways [89, 96, 97].”
From Tumor microenvironment complexity and therapeutic implications at a glance (2020) · cites this paper as [97]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Abràmoff, M. D., Magalhães, P. J., & Ram, S. J. (2004) · Utrecht University Repository (Utrecht University) · Cited by 15,374
Exploring the full spectrum of macrophage activation
Mosser, D. M., & Edwards, J. P. (2008) · Nature Reviews Immunology · doi:10.1038/nri2448 · Cited by 9,144 · cited 1×
“They probably differentiate from monocytes precursors that are restricted to blood and seed most macrophages but it cannot be ruled out that they cross-differentiate from other resident macrophages as has been described in some immune responses [61].”
BackgroundDissemination and growth of cancer cells in metastatic sites
Chambers, A. F., Groom, A. C., & MacDonald, I. C. (2002) · Nature Reviews Cancer · doi:10.1038/nrc865 · Cited by 3,911 · cited 2×
“This ability of tumor cells to establish themselves at the metastatic site is considered one of the major rate limiting steps in metastasis [1].”
BackgroundMicroenvironmental regulation of metastasis
Joyce, J. A., & Pollard, J. W. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2618 · Cited by 3,684 · cited 2×
“no direct evidence for macrophages influencing the events subsequent to homing of metastatic cells [22].”
BackgroundSelf-citationBlood Monocytes Consist of Two Principal Subsets with Distinct Migratory Properties
Geissmann, F., Jung, S., & Littman, D. R. (2003) · Immunity · doi:10.1016/s1074-7613(03)00174-2 · Cited by 3,391 · cited 1×
“This metastasisassociated CD11b+macrophage population is different from the classically defined inflammatory Gr1+CCR2+CX3CR1 macrophages and Gr1-CCR2-CX3CR1 tissue macrophages [62] and is also distinct from other recently identified macrophage populations in the primary tumor microenvironment such as myeloid suppresso…”
BackgroundTumour-educated macrophages promote tumour progression and metastasis
Pollard, J. W. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1256 · Cited by 3,367 · cited 1×
“This distinct phenotypes give further support to the notion of the tumor microenvironment educating the recruited macrophages to give functions that are advantageous to the growing tumor cells [66].”
BackgroundSelf-citationVEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche
Kaplan, R. N., Riba, R. D., Zacharoulis, S., Bramley, A. H., Vincent, L., Costa, C., MacDonald, D. D., Jin, D. K., Shido, K., Kerns, S. A., et al. (2005) · Nature · doi:10.1038/nature04186 · Cited by 3,288
Genes that mediate breast cancer metastasis to lung
Minn, A. J., Gupta, G. P., Siegel, P. M., Bos, P. D., Shu, W., Giri, D. D., Viale, A., Olshen, A. B., Gerald, W. L., & Massagué, J. (2005) · Nature · doi:10.1038/nature03799 · Cited by 2,922 · cited 1×
“To test the hypothesis that macrophage dependency is a general phenomena for breast cancer pulmonary metastasis, experimental metastasis assays were performed in nude mice using the metastatic variants of MDA-231 human breast cancer cell lines, 3475 and 4173 (kind gifts from Dr. Joan Massague (MSKCC, New York)”
MethodMacrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis
Condeelis, J., & Pollard, J. W. (2006) · Cell · doi:10.1016/j.cell.2006.01.007 · Cited by 2,695 · cited 3×
“In part, this tumor promotion by macrophages is due to their role in regulating angiogenesis [45] and to their ability to enhance tumor cell motility, invasion and intravasation (reviewed in [11]).”
BackgroundSelf-citationParadoxical roles of the immune system during cancer development
de Visser, K. E., Eichten, A., & Coussens, L. M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1782 · Cited by 2,256 · cited 1×
“Studies in primary tumors however, have also revealed major roles for the microenvironment in modulating malignancy including significant roles for resident cells such as fibroblasts and adipocytes, as well as haematopoietic cells [8,9,10,11,12,13].”
Background
Cited by
Items 201–300 of 674
Lung-resident alveolar macrophages regulate the timing of breast cancer metastasis
Dalla, E., Papanicolaou, M., Park, M. D., Barth, N. D., Hou, R., Segura-Villalobos, D., Salazar, L. E. V., Sun, D., Forrest, A. R. R., Casanova-Acebes, M., et al. (2024) · Cell · doi:10.1016/j.cell.2024.09.016 · Cited by 99
Macrophage diversity in cancer dissemination and metastasis
Mantovani, A., Marchesi, F., Mitri, D. D., & Garlanda, C. (2024) · Cellular and Molecular Immunology · doi:10.1038/s41423-024-01216-z · Cited by 109
“Seminal preclinical studies on breast cancer metastasis have shown that the metastatic seeding and persistent growth of tumor cells are dependent on macrophages [40, 41].”
BackgroundInfluentialActive Roles of Tumor Stroma in Breast Cancer Metastasis
Khamis, Z. I., Sahab, Z. J., & Sang, Q.-X. A. (2012) · International Journal of Breast Cancer · doi:10.1155/2012/574025 · Cited by 86
“Moreover, lung-resident macrophages were visualized to physically interact with tumor cells as soon as they extravasate through the vessel walls, thus promoting the rate of extravasation and metastatic dissemination [70].”
BackgroundLeone, K., Poggiana, C., & Zamarchi, R. (2018) · Diagnostics · doi:10.3390/diagnostics8030059 · Cited by 103
“Thus, the more abundant blood flow allows further accumulation of MAMs and CTCs [110,112,113].”
BackgroundAssessment of folate receptor-β expression in human neoplastic tissues
Shen, J., Putt, K. S., Visscher, D. W., Murphy, L., Cohen, C., Singhal, S. K., Sandusky, G. E., Feng, Y., Dimitrov, D. S., & Low, P. S. (2015) · Oncotarget · doi:10.18632/oncotarget.3739 · Cited by 86
“While the mechanistic underpinnings of this correlation still need to be explored, it has been established for some time that tumor-associated macrophages greatly increase the invasiveness and metastatic potential of tumors [33, 34, 35].”
BackgroundBimodal role of Kupffer cells during colorectal cancer liver metastasis
Wen, S., Ager, E. I., & Christophi, C. (2013) · Cancer Biology & Therapy · doi:10.4161/cbt.24593 · Cited by 88
Selectins as Mediators of Lung Metastasis
Laubli, H. P., & Borsig, L. (2010) · Cancer Microenvironment · doi:10.1007/s12307-010-0043-6 · Cited by 89
Maimon, A., Levi-Yahid, V., Ben‐Meir, K., Halpern, A., Talmi, Z., Priya, S., Mizraji, G., Mistriel-Zerbib, S., Berger, M., Baniyash, M., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci126089 · Cited by 89
“Similarly, Qian et al. identified a CCR2-and Gr1-positive distinct population of inflammatory monocytes that are preferentially recruited to metastatic sites over primary tumors, where they promote extravasation of tumor cells into lung parenchyma (33, 34).”
The Immune Microenvironment: A Major Player in Human Cancers
Fridman, W. H., Remark, R., Goc, J., Giraldo, N. A., Becht, E., Hammond, S. A., Damotte, D., Dieu-Nosjean, M.-C., & Sautès-Fridman, C. (2014) · International Archives of Allergy and Immunology · doi:10.1159/000362332 · Cited by 77
Pro-tumorigenic functions of macrophages at the primary, invasive and metastatic tumor site
Nasrollahzadeh, E., Razi, S., Keshavarz‐Fathi, M., Mazzone, M., & Rezaei, N. (2020) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-020-02616-6 · Cited by 89
Latest Advances in Targeting the Tumor Microenvironment for Tumor Suppression
Laplagne, C., Domagala, M., Le Naour, A., Quemerais, C., Hamel, D., Fournié, J.-J., Couderc, B., Bousquet, C., Ferrand, A., & Poupot, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20194719 · Cited by 72
“In a murine xenograft model for cutaneous T-cell lymphoma, the reduction of tumor growth was associated with a decrease in pSTAT3 and macrophage number [43]; the same association was observed in other preclinical mouse models of bone metastasis from lung cancer [44], lung metastasis from breast cancer [45], or melanom…”
BackgroundMehraj, U., Qayoom, H., & Mir, M. A. (2021) · Breast Cancer · doi:10.1007/s12282-021-01231-2 · Cited by 86
“This therapy diminished macrophage infiltration in the tumor experimental models of bone metastasis from lung cancer and lung metastasis from breast cancer and consequently restricted metastatic outgrowth [141, 142].”
BackgroundOpperman, K. S., Vandyke, K., Clark, K. C., Coulter, E. A., Hewett, D. R., Mrozik, K. M., Schwarz, N., Evdokiou, A., Croucher, P. I., Psaltis, P. J., et al. (2019) · Neoplasia · doi:10.1016/j.neo.2019.05.006 · Cited by 78
“Several studies have shown that liposomal clodronate results in decreased metastasis of solid tumors [42,43].”
Non-viral nano-immunotherapeutics targeting tumor microenvironmental immune cells
Yong, S., Chung, J. Y., Song, Y., Kim, J., Ra, S., & Kim, Y. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119401 · Cited by 84
Epigenetics in modulating immune functions of stromal and immune cells in the tumor microenvironment
Pan, X., & Zheng, L. (2020) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-0505-9 · Cited by 75
“During cancer progression, macrophages switch to an M2-like phenotype as the tumor begins to invade, vascularize, and develop.(31,32) These findings were validated using human cancer patient samples in studies of M1 and M2 macrophage using CD68 and CD204 as respective M1 and M2 macrophage markers.”
BackgroundTargeting Tumor-Associated Macrophages in Cancer Immunotherapy
Petty, A. J., Owen, D. H., Yang, Y., & Huang, X. (2021) · Cancers · doi:10.3390/cancers13215318 · Cited by 74
“Lastly, the identification of a distinct population of VEGFR1highCX3CR1highCCR2high but Tie2− macrophage at the lung metastatic site in a spontaneous breast cancer model demonstrated that macrophages not only serve to prepare the pre-metastatic niche to increase metastatic efficiency but also foster cancer cell surviv…”
BackgroundGibby, K., You, W.-K., Kadoya, K., Helgadottir, H., Young, L. J., Ellies, L. G., Chang, Y., Cardiff, R. D., & Stallcup, W. B. (2012) · Breast Cancer Research · doi:10.1186/bcr3174 · Cited by 77
“Both of these macrophage sub-populations are thought to have tumor promoting properties [26-28,53-56], consistent with our observation of delayed mammary tumor growth in NG2 null MMTV-PyMT mice.”
BackgroundNeutrophils drive accelerated tumor progression in the collagen-dense mammary tumor microenvironment
García-Mendoza, M. G., Inman, D. R., Ponik, S. M., Jeffery, J. J., Sheerar, D. S., Van Doorn, R. R., & Keely, P. J. (2016) · Breast Cancer Research · doi:10.1186/s13058-016-0703-7 · Cited by 79
“Because TAMs have an established role in tumor progression and metastasis [19, 41], the increase in macrophages may carry on with invasion and metastasis in the MMTV-PyVT tumors even after depletion of Ly6G+ cells in WT mice.”
BackgroundMuramatsu, S., Tanaka, S., Mogushi, K., Adikrisna, R., Aihara, A., Ban, D., Ochiai, T., Irie, T., Kudo, A., Nakamura, N., et al. (2013) · Hepatology · doi:10.1002/hep.26345 · Cited by 80
“Macrophages are an important component of the tumor-host interaction that controls the survival, migration, and growth of metastatic cells.(34) Our data showed that GdegROS HCC cells induced macrophage chemotaxis more effectively than their counterparts (Fig.”
Background2014 Jeffrey M. Hoeg Award Lecture: Transcriptional Control of Monocyte Development
Zhu, Y. P., Thomas, G. D., & Hedrick, C. C. (2016) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.116.304054 · Cited by 91
Bone marrow niches in the regulation of bone metastasis
Chen, F., Han, Y., & Kang, Y. (2021) · British Journal of Cancer · doi:10.1038/s41416-021-01329-6 · Cited by 88
de Vries, M. W., Hogendoorn, P. C. W., Bruyn, I. B.-D., Malessy, M. J. A., & van der Mey, A. G. L. (2012) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-012-1236-9 · Cited by 77
“Studies on breast cancer have addressed the role of the inflammatory microenvironment in tumor progression [29–35].”
BackgroundSakakura, K., Takahashi, H., Kaira, K., Toyoda, M., Murata, T., Ohnishi, H., Oyama, T., & Chikamatsu, K. (2016) · Laboratory Investigation · doi:10.1038/labinvest.2016.70 · Cited by 79
Isolation of Mouse and Human Tumor-Associated Macrophages
Cassetta, L., Noy, R., Swierczak, A., Sugano, G., Smith, H., Wiechmann, L., & Pollard, J. W. (2016) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-26666-4_12 · Cited by 79
“There are a number of methods to assess macrophage and TAM function and phenotype; these include (1) gene expression analysis [21–23]; (2) functional studies; (3) assessment of cytokine and chemokine production [24, 25]; and (4) analysis of protein expression and cell surface markers [26].”
MethodSelf-citationMetabolism in cancer metastasis: bioenergetics, biosynthesis, and beyond
Teoh, S. T., & Lunt, S. Y. (2017) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1406 · Cited by 87
“primary tumor growth and development, as well as promoting metastasis by facilitating cancer cell extravasation and growth at the secondary tumor site, likely through the secretion of proteases and motility and survival factors.(269) Altered metabolism in tumor-associated macrophages (TAMs) are also implicated in immu…”
BackgroundOrtega, R. A., Barham, W. J., Sharman, K., Tikhomirov, O., Giorgio, T. D., & Yull, F. E. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s93483 · Cited by 82
“Finally, TAMs participate in the metastatic process by creating pathways that aid in tumor cell intravasation.(16,17) It has been reported that the tumorigenic and metastatic effects generated by TAMs can be reduced or removed by ablating macrophages with liposomal clodronate in mouse models of human cancer.”
Biomechanics of the Circulating Tumor Cell Microenvironment
Krog, B. L., & Henry, M. D. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-95294-9_11 · Cited by 80
“Other studies using quantitative PCR to measure tumor cells have shown that over 85% of injected cells are present in the lung 5 min postinjection with about 20% of those cells persisting to 24 h [88].”
MethodLorenzo-Sanz, L., & Muñoz, P. (2019) · Cancer Microenvironment · doi:10.1007/s12307-019-00232-2 · Cited by 86
“However, other studies demonstrated that TAMs support tumor growth and progression [23] by promoting angiogenesis [28], enhancing invasion and metastasis [29], and protecting tumor cells from apoptosis [30].”
BackgroundSerotonin Modulation of Macrophage Polarization: Inflammation and Beyond
Casas-Engel, M. D. L., & Corbí, A. L. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-07320-0_9 · Cited by 85
Immune cell infiltration of primary and metastatic lesions: Mechanisms and clinical impact
Talmadge, J. E. (2010) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2010.12.002 · Cited by 85
Circulating Tumor Cell-Neutrophil Tango along the Metastatic Process
Saini, M., Szczerba, B. M., & Aceto, N. (2019) · Cancer Research · doi:10.1158/0008-5472.can-19-1972 · Cited by 77
“The CCL2–CXCR2 axis has been implicated as a major vulnerability in MDSC-promoted metastasis, as its blockade promotes retention of monocytes in the bone marrow, thus preventing localization in the lungs and local differentiation into functional macrophages (88, 89).”
BackgroundThe Engagement Between MDSCs and Metastases: Partners in Crime
Trovato, R., Canè, S., Petrova, V., Sartoris, S., Ugel, S., & Sanctis, F. D. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00165 · Cited by 81
“Finally, both neutrophils and inflammatory monocytes (iMos), that in cancer setting resemble MDSCs (132), can physically associate with cancer cells supporting their extravasation (133).”
BackgroundCotechini, T., Atallah, A., & Grossman, A. (2021) · Cells · doi:10.3390/cells10040960 · Cited by 82
“Macrophages are then recruited to the site of extravasating tumor cells where they promote seeding, growth, and survival of malignant cells [64].”
BackgroundResultInfluentialZheng, Y., Yang, W., Aldape, K., He, J., & Lu, Z. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.499020 · Cited by 79
“VCAM-1 Expression Is Required for EGF-induced and THP-1 Cell-mediatedGBMCell Invasion—Contact withmacrophages enhances tumor cell extravasation (12).”
BackgroundOne microenvironment does not fit all: heterogeneity beyond cancer cells
Kim, I. S., & Zhang, X. H.-F. (2016) · Cancer and Metastasis Reviews · doi:10.1007/s10555-016-9643-z · Cited by 81
“Consistent with this observation, previous studies determined that a distinct subpopulation of macrophage originated from inflammatory monocytes mediated the extravasation and colonization of tumor cells [90].”
ResultMacrophages promote the progression of premalignant mammary lesions to invasive cancer
Carron, E. C., Homra, S., Rosenberg, J. N., Coffelt, S. B., Kittrell, F. S., Zhang, Y., Creighton, C. J., Fuqua, S. A. W., Medina, D., & Machado, H. L. (2017) · Oncotarget · doi:10.18632/oncotarget.14913 · Cited by 76
“Tumor-associated macrophages in established tumors have been shown to promote breast cancer cell invasion, angiogenesis and metastasis [3, 20].”
BackgroundContribution of very late antigen-4 (VLA-4) integrin to cancer progression and metastasis
Schlesinger, M., & Bendas, G. (2015) · Cancer and Metastasis Reviews · doi:10.1007/s10555-014-9545-x · Cited by 75
Eyob, H., Ekiz, H. A., DeRose, Y. S., Waltz, S. E., Williams, M. A., & Welm, A. L. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0480 · Cited by 73
“We injected equal numbers of identical tumor cells into the tail veins of WT or Ron TK-/- mice, and examined the ability of the cells to extravasate and seed the lung (36 hours later) and the ability of the cells to form colonies (5 days later; time points are based on (34)).”
The dual roles of homeobox genes in vascularization and wound healing
Kachgal, S., Mace, K. A., & Boudreau, N. J. (2012) · Cell Adhesion & Migration · doi:10.4161/cam.22164 · Cited by 72
Heparin as an Inhibitor of Cancer Progression
Borsig, L. (2010) · Progress in molecular biology and translational science · doi:10.1016/s1877-1173(10)93014-7 · Cited by 73
Lavy, M., Gauttier, V., Poirier, N., Barillé‐Nion, S., & Blanquart, C. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.702785 · Cited by 79
Sinha, P., & Ostrand‐Rosenberg, S. (2013) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-013-1470-2 · Cited by 73
“For tumor systems in which IL-10 has pro-tumor activity, IL-10 facilitates the development of T regulatory cells (Tregs) [54], drives type 2 immune responses including tumor-promoting M2-like macrophages and type 2 CD4+ T cells, promotes tumor cell invasion, metastasis [55], and angiogenesis [56], and protects tumor c…”
Roblek, M., Protsyuk, D., Becker, P. F., Stefanescu, C., Gorzelanny, C., Garzon, J. F. G., Knopfová, L., Heikenwälder, M. F., Luckow, B., Schneider, S. W., et al. (2018) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-18-0530 · Cited by 69
“Dissemination of tumor cells during metastasis is promoted by platelet- and monocyteassisted extravasation from the circulation (3, 5, 9, 35).”
BackgroundRegulation of Inflammation by the NF-κB Pathway in Ovarian Cancer Stem Cells
Leizer, A. L., Alvero, A. B., Fu, H. H., Holmberg, J. C., Cheng, Y., Silasi, D., Rutherford, T., & Mor, G. (2010) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.2010.00914.x · Cited by 67
Myeloid cells in tumor inflammation
Schmid, M. C., & Varner, J. A. (2012) · Vascular Cell · doi:10.1186/2045-824x-4-14 · Cited by 65
“M1 macrophages are abundant at sites of chronic inflammation and in early tumors [12,13], but then switch to an M2-like phenotype during tumor progression [14-16].”
Ma, X., Wu, D., Zhou, S., Wan, F., Liu, H., Xu, X., Xu, X., Zhao, Y. F., & Tang, M. (2015) · Oncology Reports · doi:10.3892/or.2015.4357 · Cited by 68
CSF1-ETS2-induced microRNA in myeloid cells promote metastatic tumor growth
Mathsyaraja, H., Thies, K., Taffany, D. A., Deighan, C., Liu, T., Yu, L., Fernandez, S. A., Shapiro, C., Otero, J., Timmers, C., et al. (2015) · Oncogene · doi:10.1038/onc.2014.294 · Cited by 65
Galmbacher, K., Heisig, M., Hotz, C., Wischhusen, J., Galmiche, A., Bergmann, B., Gentschev, I., Goebel, W., Rapp, U. R., & Fensterle, J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009572 · Cited by 74
“Some authors have characterized TAMs as macrophages expressing protumoral functions, including promotion of tumor angiogenesis, metastasis, matrix remodelling and suppression of adaptive immunity [16,18,19,20].”
BackgroundXu, X., Zhang, Y., Jasper, J. S., Lykken, E. A., Alexander, P. B., Markowitz, G. J., McDonnell, D. P., Li, Q.-J., & Wang, X.-F. (2016) · Oncotarget · doi:10.18632/oncotarget.7953 · Cited by 70
“It has been reported that approximately 75% of cancer cells which survive in the blood circulation could extravasate by 24 hours after their intravasating [35].”
BackgroundNorton, K., Jin, K., & Popel, A. S. (2018) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2018.05.003 · Cited by 71
Singh, R., Shankar, B. S., & Sainis, K. B. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.03.028 · Cited by 68
Wartenberg, M., Zlobec, I., Perren, A. A., Koelzer, V. H., Gloor, B., Lugli, A., & Karamitopoulou, E. (2015) · Oncotarget · doi:10.18632/oncotarget.2775 · Cited by 74
Rowson-Hodel, A. R., Wald, J. H., Hatakeyama, J., O’Neal, W. K., Stonebraker, J. R., VanderVorst, K., Saldana, M., Borowsky, A. D., Sweeney, C. A., & Carraway, K. L. (2017) · Oncogene · doi:10.1038/onc.2017.327 · Cited by 65
“Disseminated tumor cells are thought to interact with immune cells and platelets 13,25 , which may potentiate their demise 15 or promote their survival 2,14,40 .”
Alveolar Macrophages Drive Hepatocellular Carcinoma Lung Metastasis by Generating Leukotriene B4
Nosaka, T., Baba, T., Tanabe, Y., Sasaki, S., Nishimura, T., Imamura, Y., Yurino, H., Hashimoto, S., Arita, M., Nakamoto, Y., et al. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1700544 · Cited by 64
“present in the interstitial space of metastatic lungs and are capable of promoting metastasis (5, 6, 31, 49).”
BackgroundInfluentialFernández, A., Thompson, E. J., Pollard, J. W., Kitamura, T., & Vendrell, M. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201910955 · Cited by 67
Self-citationDisabled Homolog 2 Controls Prometastatic Activity of Tumor-Associated Macrophages
Marigo, I., Trovato, R., Hofer, F., Ingangi, V., Desantis, G., Leone, K., Sanctis, F. D., Ugel, S., Canè, S., Simonelli, A., et al. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-0036 · Cited by 71
Murakami, M., Giampietro, C., Giannotta, M., Corada, M., Torselli, I., Orsenigo, F., Cocito, A., D’Ario, G., Mazzarol, G., Confalonieri, S., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021242 · Cited by 64
“The metastatic ratio was evaluated by removing the lungs from anesthetized mice and inspecting metastatic nodules on the lung surface by using a stereoscope (Nikon SMZ800 stereoscope 63–5, Tokyo, Japan) as described [13].”
MethodMacrophage phenotype-switching in cancer
Zhang, J., Zhou, X., & Hao, H. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.175229 · Cited by 67
Zou, J., Guo, P., Lv, N., & Huang, D. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.4243 · Cited by 68
“Alternative activation of various cell types, including tumor-associated macrophages (47), cancer‑related fibroblasts (48) and aberrantly activated neutrophils (49) have been identified in numerous types of cancer, including breast (50) and colorectal cancer (51), and melanoma (52).”
lnflammation-induced epigenetic switches in cancer
Rokavec, M., Öner, M. G., & Hermeking, H. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-2045-5 · Cited by 71
“As shown in an animal model of BC lung metastasis, a distinct type of monocyte-derived macrophages directly interacts with the extravasating cancer cells, and loss of these macrophages dramatically reduces the number of cancer cells that extravasate from the blood vessels [108].”
BackgroundFend, L., Accart, N., Kintz, J., Cochin, S., Reymann, C., Pogam, F. L., Marchand, J.-B., Menguy, T., Slos, P., Rooke, R., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073310 · Cited by 64
“It had already been shown that progression through malignant and metastatic stages of PyMT tumors depended on CSF-1 and TAMs [5,16].”
BackgroundHypoxia-inducible factors as key regulators of tumor inflammation
Mamlouk, S., & Wielockx, B. (2013) · International Journal of Cancer · doi:10.1002/ijc.27901 · Cited by 61
“For example, in a breast cancer model, using primary MMTV-PyMT-cells inoculated into Csf1 knockout mice, TAMs have been shown to mediate extravasation, establishment and growth of metastasis.(132) Much of the regulation of gene expression stated in the angiogenesis-section is likely to have an influence on metastasis.”
MethodTherapeutic potential of chemokine signal inhibition for metastatic breast cancer
Kitamura, T., & Pollard, J. W. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.08.004 · Cited by 61
Self-citationNakasone, Y., Fujimoto, M., Matsushita, T., Hamaguchi, Y., Huu, D. L., Yanaba, M., Sato, S., Takehara, K., & Hasegawa, M. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.09.005 · Cited by 63
Entenberg, D. R., Rodríguez-Tirado, C., Kato, Y., Kitamura, T., Pollard, J. W., & Condeelis, J. S. (2015) · IntraVital · doi:10.1080/21659087.2015.1086613 · Cited by 63
Self-citationTargeting monocytes/macrophages in fibrosis and cancer diseases: Therapeutic approaches
Conte, E. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.108031 · Cited by 64
Perivascular niches: critical hubs in cancer evolution
Nowosad, A., Marine, J., & Karras, P. (2023) · Trends in cancer · doi:10.1016/j.trecan.2023.06.010 · Cited by 62
The inflammatory microenvironment in brain metastases: potential treatment target?
Berghoff, A. S., & Preusser, M. (2015) · PubMed · doi:10.3978/j.issn.2304-3865.2015.06.03 · Cited by 61
“After the trans-passing of the endothelium, TAMs promote cell survival, growth and invasion via the maintenance of CSF1 signaling within the perivascular niche (20,21).”
BackgroundMicroenvironment in metastasis: roadblocks and supportive niches
Pein, M., & Óskarsson, T. (2015) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00145.2015 · Cited by 63
Dagenais, M., Dupaul-Chicoine, J., Douglas, T., Champagne, C., Morizot, A., & Saleh, M. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1287247 · Cited by 66
“This is due to the active role of macrophages, specifically Gr1C inflammatory monocytes,(46) in enabling tumor extravasation at secondary metastatic sites and in promoting metastasis survival and growth.(66) Our results indicating increased TAM frequency in PyMT/Il1r1¡/¡ mice compared with PyMT controls suggest”
BackgroundYang, S., Zhou, Y., Sun, Y., Wang, Y., Yin, J., Huang, Y., Zhang, J., He, A., Han, K., Zhang, H., et al. (2018) · Journal of Molecular Medicine · doi:10.1007/s00109-018-1711-0 · Cited by 58
Cancer cell CCR2 orchestrates suppression of the adaptive immune response
Fein, M. R., He, X., Almeida, A. S., Bružas, E., Pommier, A., Yan, R., Eberhardt, A., Fearon, D. T., Aelst, L. V., Wilkinson, J. E., et al. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20181551 · Cited by 59
Exploring the role of CHI3L1 in “pre-metastatic” lungs of mammary tumor-bearing mice
Libreros, S., Garcia‐Areas, R., Keating, P., Carrió, R., & Iragavarapu‐Charyulu, V. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00392 · Cited by 58
“At metastatic sites, specific populations of myeloid cells, i.e., CD11b+Gr1+ cells, have been found to promote tumor cell extravasation, seeding and persistent growth (Qian et al., 2009, 2011; Yan et al., 2010).”
BackgroundTumor cell-activated CARD9 signaling contributes to metastasis-associated macrophage polarization
Yang, M. H., Shao, J.-H., Miao, Y.-J., Cui, W., Qi, Y.-F., Jh, H., Lin, X., & Du, J. (2014) · Cell Death and Differentiation · doi:10.1038/cdd.2014.45 · Cited by 60
“It was previously demonstrated that, at metastatic sites, a distinct population of metastasis-associated macrophages promotes the extravasation, seeding and persistent growth of tumor cells.(13,21) CARD9, an adaptor protein of innate immune responses, has been found to have a prominent role in the pathogenesis of immu…”
BackgroundDrug Development for Metastasis Prevention
Fontebasso, Y., & Dubinett, S. M. (2015) · Critical Reviews™ in Oncogenesis · doi:10.1615/critrevoncog.v20.i5-6.150 · Cited by 66
The Tumor Microenvironment of Colorectal Cancer Metastases: Opportunities in Cancer Immunotherapy
Kamal, Y., Schmit, S. L., Frost, H. R., & Amos, C. I. (2020) · Immunotherapy · doi:10.2217/imt-2020-0026 · Cited by 61
“A distinct subset of tumor-associated macrophages, known as metastasis-associated macrophages (MAMs), originate from inflammatory monocytes and are recruited to the site of metastasis to promote growth of metastases and tumor dissemination [45,55].”
BackgroundImmunotherapeutic modulation of the suppressive liver and tumor microenvironments
Chan, T., Wiltrout, R. H., & Weiss, J. M. (2011) · International Immunopharmacology · doi:10.1016/j.intimp.2010.12.024 · Cited by 57
Syndecan-1 induction in lung microenvironment supports the establishment of breast tumor metastases
Chute, C. L., Yang, X., Meyer, K. K., Yang, N., O’Neil, K., Kasza, I., Eliceiri, K. W., Alexander, C. M., & Friedl, A. (2018) · Breast Cancer Research · doi:10.1186/s13058-018-0995-x · Cited by 59
Ash, S. A., & Buggy, D. J. (2013) · Best practice & research. Clinical anaesthesiology · doi:10.1016/j.bpa.2013.10.005 · Cited by 61
Pham, K., Huynh, D. L., Le, L., Delitto, D., Yang, L., Huang, J., Kang, Y., Steinberg, M. B., Li, J., Zhang, L., et al. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.08.010 · Cited by 66
Self-citationGPCR Signaling Mediates Tumor Metastasis via PI3Kβ
Khalil, B. D., Hsueh, C., Cao, Y., Saab, W. F. A., Wang, Y., Condeelis, J. S., Bresnick, A. R., & Backer, J. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-1675 · Cited by 59
Chemokines orchestrate tumor cells and the microenvironment to achieve metastatic heterogeneity
Saxena, S., & Singh, R. K. (2021) · Cancer and Metastasis Reviews · doi:10.1007/s10555-021-09970-6 · Cited by 57
Mukhtar, R. A., Moore, A. P., Nseyo, O., Baehner, F. L., Au, A., Moore, D. H., Twomey, P. L., Campbell, M. J., & Esserman, L. J. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1646-4 · Cited by 55
“In animal models, TAMs promote tumor growth and metastases [38, 39].”
BackgroundUpregulation of RET induces perineurial invasion of pancreatic adenocarcinoma
Amit, M., Na’ara, S., Leider–Trejo, L., Binenbaum, Y., Kulish, N., Fridman, E., Shabtai-Orbach, A., Wong, R. J., & Gil, Z. (2017) · Oncogene · doi:10.1038/onc.2016.483 · Cited by 57
Calorini, L., & Bianchini, F. (2010) · Cell Communication and Signaling · doi:10.1186/1478-811x-8-24 · Cited by 51
“Moreover, blocking macrophage lodgement at the metastatic site limits the growth of metastatic cells, even if metastatic lesions have readily been established [75].”
BackgroundMechanisms of Organ-Specific Metastasis of Breast Cancer
Nolan, E., Kang, Y., & Malanchi, I. (2023) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041326 · Cited by 61
A bi-directional dialog between vascular cells and monocytes/macrophages regulates tumor progression
Delprat, V., & Michiels, C. (2021) · Cancer and Metastasis Reviews · doi:10.1007/s10555-021-09958-2 · Cited by 54
Gillgrass, A. E., Gill, N., Babian, A., & Ashkar, A. A. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1303175 · Cited by 57
“They contribute both to the extravasation of the tumor cells and growth at the metastatic site (17, 18).”
BackgroundInfluentialDovas, A., Patsialou, A., Harney, A. S., Condeelis, J. S., & Cox, D. (2012) · Journal of Microscopy · doi:10.1111/j.1365-2818.2012.03667.x · Cited by 50
“…distinct subpopulation of macrophages (expressing the markers F4/80, CSF-1R, CD11b, VEGFR, CCR2 and lacking expression of Gr1), which differs from the resident lung macrophages, is recruited to the lungs of mammary tumourbearing mice (Qian et al., 2009; Qian et al., 2011; Gil-Bernabe et al., 2012).”
BackgroundInfluentialMathematical Modeling of Interleukin-35 Promoting Tumor Growth and Angiogenesis
Liao, K., Bai, X., & Friedman, A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110126 · Cited by 53
Slug Promotes Survival during Metastasis through Suppression of Puma-Mediated Apoptosis
Kim, S., Yao, J., Suyama, K., Qian, X., Qian, B.-Z., Bandyopadhyay, S., Loudig, O., De Leon-Rodriguez, C., Zhou, Z. N., Segall, J., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2591 · Cited by 51
“To determine if Slug affects survival of tumor cells in the blood circulation before arrest in the lungs, we tracked PyMTN-cad cells in the lungs 5minutes after tail vein injection using PyMT qPCR (30).”
InfluentialSelf-citationJones, J., Sinder, B. P., Paige, D. J., Soki, F. N., Koh, A. J., Thiele, S., Shiozawa, Y., Hofbauer, L. C., Daignault, S. D., Roca, H., et al. (2018) · Neoplasia · doi:10.1016/j.neo.2018.11.003 · Cited by 52
“Metastatic tumor cells require CD115positive macrophages for extravasation and growth in metastatic sites [39].”
Tumor-Associated Macrophages: Combination of Therapies, the Approach to Improve Cancer Treatment
Moeini, P., & Niedźwiedzka‐Rystwej, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22137239 · Cited by 54
CXCL10 conditions alveolar macrophages within the premetastatic niche to promote metastasis
Shang, C., Sun, Y., Wang, Y., Shi, H., Han, X., Mo, Y., Wang, D., Ke, Y., & Zeng, X. (2022) · Cancer Letters · doi:10.1016/j.canlet.2022.215667 · Cited by 51
Cancer evolution and individual susceptibility
Pérez‐Losada, J., Castellanos‐Martín, A., & Mao, J. (2011) · Integrative Biology · doi:10.1039/c0ib00094a · Cited by 55
Makela, A. V., & Foster, P. J. (2018) · Magnetic Resonance in Medicine · doi:10.1002/mrm.27081 · Cited by 49
Rafat, M., Aguilera, T. A., Vilalta, M., Bronsart, L. L., Soto, L. A. C., von Eyben, R., Golla, M. A., Ahrari, Y., Melemenidis, S., Afghahi, A., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-3623 · Cited by 58
“pre-metastatic niche but also to circulating metastatic cells as they begin extravasation (36).”
BackgroundIn-vitro and in-vivo difference in gene delivery by lithocholic acid-polyethyleneimine conjugate
Wang, J., Meng, F., Kim, B.-K., Ke, X., & Yeo, Y. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119296 · Cited by 50
“The TAM population is known to increase with tumor progression [32, 33].”
BackgroundRoy, S. M., Garg, V., Barman, S., Ghosh, C., Maity, A. R., & Ghosh, S. K. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.785937 · Cited by 54
“, 2019), tumorassociated macrophages (TAMs) (Qian et al., 2009; Noy and Pollard, 2014; Larionova et al., 2019; Lin et al., 2019), tumorassociated neutrophils (TANs), mesenchymal stem cells and extracellular matrix (ECM) with fibrous structural proteins (e.”
BackgroundTissue-resident immunity in the lung: a first-line defense at the environmental interface
Zazara, D. E., Belios, I., Lücke, J., Zhang, T., & Giannou, A. D. (2022) · Seminars in Immunopathology · doi:10.1007/s00281-022-00964-2 · Cited by 48
“In accordance to these findings, intratracheal L-Clodronate-mediated AM depletion did not affect lung metastasis of mammary carcinomaderived Met-1 cells [277].”
Result
Metadata
- Authors
- Qian, B., Deng, Y., Im, J. H., Muschel, R. J., Zou, Y., Li, J., Lang, R. A., & Pollard, J. W.
- Affiliations
- Albert Einstein College of Medicine (US)
- Churchill Hospital (GB)
- Cincinnati Children's Hospital Medical Center (US)
- Corresponding author
- Pollard, Jeffrey W.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2009-08-10
- Volume
- 4
- Issue
- 8
- Pages
- e6562
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC2721818
- OpenAlex
- W2117776343
- Cited by
- 664
- References
- 70
- Citations by year
- 2026: 16 · 2025: 26 · 2024: 26 · 2023: 30 · 2022: 50 · 2021: 60 · 2020: 43 · 2019: 45 · 2018: 49 · 2017: 39 · 2016: 38 · 2015: 44 · 2014: 38 · 2013: 48 · 2012: 42
- FWCI
- 15.78
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- National Institutes of Health (PO1#CA100324)
- National Cancer Institute (P01CA100324, R01CA094173, P30CA013330)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Stress, Anesthesia, and Immune Response
- Keywords
- tumor-associated macrophages, breast cancer metastasis, tumor cell extravasation, lung metastasis, metastatic seeding, metastatic growth, macrophage depletion, tumor microenvironment, therapeutic target
- MeSH terms
- Animals, Cell Division, Disease Models, Animal, Female, Macrophages, Mammary Neoplasms, Experimental, Neoplasm Metastasis, CD11b Antigen, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.